Document is current

Any future updates will be listed below

High-dose interleukin2 – a 10-year single-site experience in the treatment of metastatic renal cell carcinoma: careful selection of patients gives an excellent outcome

Crossref DOI link: https://doi.org/10.1186/s40425-016-0174-5

Published Online: 2016-10-18

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark